共 50 条
- [41] Radioiodine remnant ablation in differentiated thyroid cancer after combined endogenous and exogenous TSH stimulation NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2012, 51 (03): : 67 - 72
- [43] Recurrence Rate of Tumor and the Value of Diagnostic I-131 Whole Body Scintigraphy and Recombinant TSH in Low-Risk Well Differentiated Thyroid Cancer Patients Who Have Had I-131 Radioablation TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2012, 32 (06): : 1693 - 1701
- [45] Management of differentiated thyroid cancer through nuclear medicine facilities during Covid-19 emergency: the telemedicine challenge European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 831 - 836
- [47] Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspective Reviews in Endocrine and Metabolic Disorders, 2024, 25 : 109 - 121
- [49] Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1001 - 1005